Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Vitamin D numbers: what they really mean

Testing your patients for vitamin D1,2

Many physicians recognize the importance of testing vitamin D levels in their high-risk patients, such as older adults and those who are dark-skinned or receive little or no sun exposure. Patients with low vitamin D levels are at risk of osteoporosis and cardiovascular disease, as well as cancer and respiratory disease. Patients who are pregnant or lactating should be tested too, since they represent another high-risk group. Deficiency in pregnancy can lead to preeclampsia, and deficiency while lactating can cause rickets in infants.

An important part of the testing process is advising patients on their vitamin D supplementation needs based on their test results. Here’s what you need to know.

What do vitamin D tests measure?1,2

Vitamin D tests, which include immunoassays and liquid chromatography-mass spectrometry LC/MS/MS, measure the level of 25(OH)D, the main form of circulating vitamin D.

Optimal levels

Vitamin D levels of 30 to 100 ng/mL are considered optimal.

Low levels—suboptimal

Vitamin D levels between 20 and 29 ng/mL are considered suboptimal. Vitamin D insufficiency may lead to elevated parathyroid hormone (PTH) levels (secondary hyperparathyroidism).

Low levels—deficiency

Vitamin D levels <20 ng/mL are considered vitamin D deficient.

Vitamin D deficiency may lead to elevated parathyroid hormone (PTH) levels (secondary hyperparathyroidism).

If your patients' test results reveal that they are vitamin D deficient, the Endocrine Society recommends that they receive vitamin D supplementation. (See the chart below.)

Additional considerations

Monitor serum calcium levels in order to prevent hypercalcemia in patients with
extrarenal production of 1,25(OH)D and in those with primary hyperparathyroidism.

Recommendations for supplementation in vitamin D-deficient patients1

Supplementation in vitamin D-deficient patients depends on your patient's age and medical history. Use this table as a guide to help you advise your patients on recommendations for supplementation:

Recommendations for supplementation in Vitamin D-deficient patients

  Daily Weekly Maintenance*

Infants and toddlers
(0-1 year)

2,000 IU
(for 6 weeks)

50,000 IU
(for 6 weeks)

400-1,000 IU/day

Children
(1 to 18 years)

2,000 IU
(for at least 6 weeks)

50,000 IU
(for at least 6 weeks)

600-1,000 IU/day

Adults

6,000 IU
(for 8 weeks)

50,000 IU
(for 8 weeks)

1,500-2,000 IU/day

Obese Patients / Patients with malabsorbtion syndromes / Patiens taking certain medications

6,000-10,000 IU

N/A

3,000-6,000 IU/day


*After achieving 25(OH)D levels >30 ng/mL.

Specific supplementation guidelines are not available for pregnant and lactating women. Both groups should be advised to supplement if tests show low levels of vitamin D.

Take action

Learn more about vitamin D testing and how best to manage your patients with low vitamin D levels.

References

  1. Holick M, Binkley N, Bischoff-Ferrari H, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
  2. Khan Q, Fabian C. How I treat vitamin D deficiency. JOP. 2010;6(2):97-101.

During the COVID-19 health crisis, fast action and trusted information matter more than ever.

Find out what's happening

Learn More

Endocrine disorders

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.